11 – 20 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics
(
- Contribution to journal › Article
-
Mark
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice : A prospective cohort study
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
(
- Contribution to journal › Article
-
Mark
Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA : Results from the nationwide Swedish register
(
- Contribution to journal › Article
- 2018
-
Mark
Mantle cell lymphoma strategies in primary treatment
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
(
- Contribution to journal › Debate/Note/Editorial
- 2017
-
Mark
Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014 : An analysis of the Swedish Lymphoma Registry
(
- Contribution to journal › Article
-
Mark
Rituximab in clinical practice : dosage, drug adherence, Ig levels, infections, and drug antibodies
(
- Contribution to journal › Article
- 2016
-
Mark
Burkitt lymphoma and diffuse large B-cell lymphoma – therapeutic strategies and pathogenetic mechanisms
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Rituximab for treatment of severe renal disease in ANCA associated vasculitis
(
- Contribution to journal › Article